CoreWeave Q3 Shows Execution, But Profits Remain Elusive

What happened

The Motley Fool article confirms that CoreWeave's latest earnings reflect strong operational execution, with revenue growth on track, but the central challenge remains converting that growth into profits. The prior master report set Q3 2026 revenue guidance at $3.45–$3.60 billion and adjusted operating income at $200–$260 million, and the article's tone suggests these targets were likely met or exceeded. However, GAAP operating income remained negative or only marginally positive, as Q2 2026 showed a -$49 million operating loss, and Q3 interest expense was guided to $860–$940 million, which likely kept net income deeply negative. The company's backlog and contracted power continue to expand, but heavy debt of $35.6 billion and lease liabilities of $16.3 billion keep financing costs a significant drag on bottom-line results. The stock reaction has been muted relative to growth, indicating that the market is now focused on the profitability inflection rather than top-line momentum.

Implication

Investors should monitor whether Q3 and Q4 show sustained revenue conversion and a declining interest burden, as these are critical to validating the thesis. While execution appears on track, the stock still embeds a premium for growth that has not yet produced clean earnings, and the WAIT rating remains appropriate. Attractive entry is around $90, while trimming above $130 is prudent given the lack of margin of safety. The next six months will test whether CoreWeave can maintain liquidity without dilutive financing as capex guidance of $35–$39 billion for FY2026 remains massive. Until GAAP operating income turns positive and interest coverage improves from the current -0.3x, the risk-reward for new money is not compelling.

Thesis delta

No material change to the WAIT thesis; the article confirms operational execution is progressing as expected, with growth strong but profitability still constrained by high financing costs and depreciation. The core risk remains whether revenue conversion can outpace the mounting interest burden. Until GAAP profits appear, the valuation lacks a margin of safety, and the next checkpoint is year-end commenced-delivery backlog exceeding two-thirds.